Mabwell (shanghai) Bioscience Co., Ltd.
Clinical trials sponsored by Mabwell (shanghai) Bioscience Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New shot may help heal tough scars Results expected Dec 2026 (estimated)
- New hope for tough breast cancer: experimental drug BFv targets tumors after other treatments fail Results expected May 2027 (estimated)
- New hope for stubborn gut cancers? early trial launches Results expected Jul 2027 (estimated)
- New hope for advanced tumors? first human trial of 7MW4911 begins Results expected Jul 2027 (estimated)